<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371395</url>
  </required_header>
  <id_info>
    <org_study_id>6619</org_study_id>
    <nct_id>NCT02371395</nct_id>
  </id_info>
  <brief_title>Validation of RealAmp Method for the Diagnosis of Malaria in Endemic Areas of Brazil</brief_title>
  <official_title>Validation of RealAmp Method for the Diagnosis of Malaria in Endemic Areas of Brazil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Evandro Chagas Institute of Clinical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centers for Disease Control and Prevention</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Worldwide, approximately 2 billion people live in areas at risk for malaria with morbidity
      surpassing 250 million cases, with approximately 800,000 deaths, per year. Of the four
      species of malaria parasites that cause human infection, P. falciparum is responsible for the
      majority of severe malaria cases followed by P. vivax. Early and accurate diagnosis is
      essential for prompt and correct treatment, which can reduce the death rate and interrupt
      transmission. Currently, conventional methods for the diagnosis of malaria include
      microscopic examination of thin and thick blood smears and rapid diagnostic tests (RDTs).
      Light microscopy in practice typically detects parasitemia as low as 100 parasites/Âµl and it
      can differentiate species. The advantage of microscopy includes the ability to estimate
      parasitemia, the possibility to identify parasite stages, including gametocytes, and its low
      cost. However, this method is labor intensive, difficult to standardize, and requires
      well-trained microscopists. The majority of RDTs are based on detection of P. falciparum
      histidine-rich protein 2 (HRP-2) antigen and do not detect all malaria species. RDTs that
      detect lactose dehydrogenase (LDH) and aldolase generally broadly react with all four species
      of malaria parasites and therefore cannot differentiate among the species although efforts
      are underway to improve their performance for species detection. In settings where multiple
      malaria species co-circulate, molecular methods may be more reliable than microscopy and RDTs
      in accurately diagnosing the species of malaria parasites with low parasitemias. However,
      conventional molecular methods, such as nested polymerase chain reaction (nested PCR) or
      real-time PCR, are technically challenging and resource intensive and are generally
      restricted to reference laboratories due to the need for well-equipped laboratories.
      Recently, new molecular methods that can be used in field settings have been developed and
      this opens up new opportunities for exploring molecular tools for malaria diagnosis in
      endemic countries. With the objective of facilitating use of molecular tools for malaria
      control programs, the malaria laboratory at the Centers for Disease Control and Prevention
      (CDC) in Atlanta, USA developed a simple isothermal molecular method called Real-Time
      Fluorescence Loop-Mediated Isothermal Amplification (RealAmp) for the diagnosis of malaria.
      Currently, RealAmp primers exist for detecting the Plasmodium genus and the detection of P.
      falciparum and P. vivax species. The RealAmp method has great potential as a molecular tool
      for the diagnosis of malaria in the field (and other infections of major public health
      impact, such as HIV and tuberculosis). It can provide an alternative to conventional
      PCR-based diagnostic methods for field use in clinical and operational programs. The
      objective of this proposal is to validate the sensitivity of RealAmp for detection of malaria
      parasites in blood spots from patients with clinical diagnosis of malaria in two endemic
      states of Brazil with co-circulation of P. falciparum and P. vivax. In this evaluation,
      RealAmp and microscopic examination will be compared to a real-time PCR method as a reference
      test.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Malaria Diagnosis Using RealAmp and Microscopy.</measure>
    <time_frame>12 months</time_frame>
    <description>These are the results of the different tests used in the evaluation.</description>
  </primary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>Malaria Diagnosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Realtime amplification (RealAmp)</intervention_name>
    <description>Molecular assay for the diagnosis of malaria.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with fever who present for malaria diagnosis and regular health posts.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 7 years

          -  Signed informed consent for patients 18 years and older

          -  Signed parental/guardian consent form and assent from the patient (for those less than
             18 years)

          -  Documented fever (auxiliary temperature greater than 37.5C) or self-reported fever in
             previous 24 hours in the absence of another obvious cause of fever

          -  First visit for current illness at the diagnostic post

        Exclusion Criteria:

          -  Absence of fever or no history of fever

          -  Follow-up visit for the current illness

          -  No consent/assent to participate

          -  Antimalarial treatment use in previous 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Macedo de Oliveira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centers for Disease Control and Prevention</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital do Jurua</name>
      <address>
        <city>Cruzeiro do Sul</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <results_first_submitted>May 17, 2017</results_first_submitted>
  <results_first_submitted_qc>February 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 23, 2018</results_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Patients With Suspected Malaria (Fever)</title>
          <description>This was a study of enrolling patients with fever or history of fever for malaria testing. A total of 1,000 samples were collected from patients in Cruzeiro do Sul, Acre state from January to June, 2015.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1000"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1000"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Arm</title>
          <description>This was a study of enrolling patients with fever or history of fever for malaria testing. A total of 1,000 samples were collected from patients in Cruzeiro do Sul, Acre state from January to June, 2015.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1000"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1000"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.5" lower_limit="7" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1000"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="551"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="449"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1000"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Malaria Diagnosis Using RealAmp and Microscopy.</title>
        <description>These are the results of the different tests used in the evaluation.</description>
        <time_frame>12 months</time_frame>
        <population>Those were patients presenting with suspected malaria.</population>
        <group_list>
          <group group_id="O1">
            <title>Single Arm</title>
            <description>This was a study of enrolling patients with fever or history of fever for malaria testing. A total of 1,000 samples were collected from patients in Cruzeiro do Sul, Acre state from January to June, 2015.</description>
          </group>
        </group_list>
        <measure>
          <title>Malaria Diagnosis Using RealAmp and Microscopy.</title>
          <description>These are the results of the different tests used in the evaluation.</description>
          <population>Those were patients presenting with suspected malaria.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1000"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of positive samples by local microscopy</title>
              <category_list>
                <category>
                  <title>P. falciparum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>P. vivax</title>
                  <measurement_list>
                    <measurement group_id="O1" value="153"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mixed infection</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Species unidentified</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="804"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of positive samples by study microscopy</title>
              <category_list>
                <category>
                  <title>P. falciparum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                  </measurement_list>
                </category>
                <category>
                  <title>P. vivax</title>
                  <measurement_list>
                    <measurement group_id="O1" value="169"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mixed infection</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Species unidentified</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="774"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of positive samples by RealAmp</title>
              <category_list>
                <category>
                  <title>P. falciparum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>P. vivax</title>
                  <measurement_list>
                    <measurement group_id="O1" value="181"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mixed infection</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Species unidentified</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="761"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of positive samples by reference test</title>
              <category_list>
                <category>
                  <title>P. falciparum</title>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>P. vivax</title>
                  <measurement_list>
                    <measurement group_id="O1" value="152"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mixed infection</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Species unidentified</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="780"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Single Arm</title>
          <description>This was a study of enrolling patients with fever or history of fever for malaria testing. A total of 1,000 samples were collected from patients in Cruzeiro do Sul, Acre state from January to June, 2015.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1000"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1000"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alexandre Macedo de Oliveira</name_or_title>
      <organization>CDC</organization>
      <phone>404 718 4751</phone>
      <email>acq7@cdc.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

